Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid TumorsAmita Patnaik, Anthony W. Tolcher, Drew Rasco et al.|Clinical Cancer Research|2015Cited by 799